US · Technology · Software - Infrastructure
EPS came in at 0.05 against a street estimate of 0.09 — a miss of 44.4%.
Analysts rate Cellebrite DI a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $15.36.
| Fund | Stake |
|---|---|
| True Wind Capital Management, L.P. | 5.51% |
| Voss Capital LLC | 4.55% |
| Pertento Partners LLP | 3.18% |
| Phoenix Financial Ltd | 2.46% |
| FMR Inc | 2.38% |
| BlackRock Inc | 2.26% |
| Nine Ten Capital Management LLC | 1.64% |
| Artisan Partners Limited Partnership | 1.30% |
| Document | Date |
|---|---|
| Report of foreign private issuer (6-K) · Q3 2026 HEADLINE NUMBERS • 204,331,510 ordinary shares were present or represented by proxy at Cellebrite’s annual general meeting on September 24, 2026. • | 2026-09-24 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • As of August 1, 2026, Cellebrite had 251,341,060 ordinary shares outstanding. • Outstanding awards under the 2021 Share Incentive | 2026-09-02 |
| Report of foreign private issuer (6-K) · Q3 2026 HEADLINE NUMBERS • 2025 annual recurring revenue (ARR) grew 21% to $480.8 million. • Total revenue increased 19% to $475.7 million, driven by 21% su | 2026-08-18 |
| Report of foreign private issuer (6-K) · Q3 2026 HEADLINE NUMBERS • No financial results, revenue figures, earnings, cash-flow data, or operating metrics were disclosed in this filing. • The report | 2026-08-13 |
| Annual report FY2025 (20-F) BUSINESS & SEGMENT HIGHLIGHTS • Cellebrite provides AI-powered digital investigative and intelligence software and services for legally sanctioned in | 2026-03-03 |
| Annual report FY2024 (20-F) | 2025-03-18 |
| Annual report FY2023 (20-F) | 2024-03-21 |
| Annual report FY2022 (20-F) | 2023-04-27 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cellebrite DI — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.